Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory C Connolly

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Thrombosis Research|May 4, 2010
Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk scoreGregory C Connolly, Alok A Khorana
Hematology. American Society of Hematology. Education Program|December 10, 2013
Cancer-associated thrombosisGregory C Connolly, Charles W Francis
Best Practice & Research. Clinical Haematology|March 17, 2009
Risk stratification for cancer-associated venous thromboembolismGregory C Connolly, Alok A Khorana
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Assessing risk of venous thromboembolism in the patient with cancerAlok A Khorana, Gregory C Connolly
Biochimica Et Biophysica Acta|February 21, 2002
Inhibition of Mrp2- and Ycf1p-mediated transport by reducing agents: evidence for GSH transport on rat Mrp2James F Rebbeor, Gregory C Connolly, Nazzareno Ballatori
Seminars in Oncology|July 16, 2014
Platelets and cancer-associated thrombosisGregory C Connolly, Richard P Phipps, Charles W Francis
Cancer|August 16, 2012
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United StatesAlok A Khorana, Mehul Dalal, Jay Lin, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 23, 2013
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United StatesAlok A Khorana, Mehul R Dalal, Jay Lin, et al.
Clinical Lung Cancer|July 30, 2013
Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patientsGregory C Connolly, Laurel Menapace, Saman Safadjou, et al.
BMC Gastroenterology|January 16, 2013
Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinomaGregory C Connolly, Saman Safadjou, Randeep Kashyap, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Thrombosis Research|May 4, 2010
Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk scoreGregory C Connolly, Alok A Khorana
Hematology. American Society of Hematology. Education Program|December 10, 2013
Cancer-associated thrombosisGregory C Connolly, Charles W Francis
Best Practice & Research. Clinical Haematology|March 17, 2009
Risk stratification for cancer-associated venous thromboembolismGregory C Connolly, Alok A Khorana
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Assessing risk of venous thromboembolism in the patient with cancerAlok A Khorana, Gregory C Connolly
Biochimica Et Biophysica Acta|February 21, 2002
Inhibition of Mrp2- and Ycf1p-mediated transport by reducing agents: evidence for GSH transport on rat Mrp2James F Rebbeor, Gregory C Connolly, Nazzareno Ballatori
Seminars in Oncology|July 16, 2014
Platelets and cancer-associated thrombosisGregory C Connolly, Richard P Phipps, Charles W Francis
Cancer|August 16, 2012
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United StatesAlok A Khorana, Mehul Dalal, Jay Lin, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 23, 2013
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United StatesAlok A Khorana, Mehul R Dalal, Jay Lin, et al.
Clinical Lung Cancer|July 30, 2013
Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patientsGregory C Connolly, Laurel Menapace, Saman Safadjou, et al.
BMC Gastroenterology|January 16, 2013
Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinomaGregory C Connolly, Saman Safadjou, Randeep Kashyap, et al.
Pageof 2